Amino acids 1-29 of the adenovirus serotypes 12 and 2 E1A proteins interact with rap30 (TF(II)F) and TBP in vitro

Virus Research

Volumn 54, Issue 1, 1998, Pages

  Lipinski, Kai S ^a   Esche, Helmut ^a   Brockmann, Dieter ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

Adenovirus type 12; E1A; TBP; TF(II)F; Transcriptional regulation

Indexed keywords

ADENOVIRUS 12; ARTICLE; GENE CONTROL; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TATA BOX; TRANSCRIPTION REGULATION; VIRUS GENE;

ADENOVIRUS E1A PROTEINS; ADENOVIRUSES, HUMAN; AMINO ACID SEQUENCE; AMINO ACIDS; BINDING SITES; DNA-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; SEROTYPING; TATA-BOX BINDING PROTEIN; TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS, TFII;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 12;

EID: 0002784589     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(98)00003-3     Document Type: Article

References (26)

1. Angel P., Karin M. The role of Jun, Fos and AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157.
2. Aronheim A., Zandi E., Hennemann H., Elledge S.J., Karin M. Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol. Cell. Biol. 17(6):1997;3094-3102.
3. Bayley S.T., Mymryk J.S. Adenovirus E1A proteins and transformation. Int. J. Oncol. 5:1994;425-444.
4. Brockmann D., Feng L., Kröner G., Tries B., Esche H. Adenovirus type 12 early region E1A expresses a 52R protein repressing the trans-activating activity of transcription factor c-Jun/AP-1. Virology. 198:1994;717-723.
5. Brockmann D., Esche H. Regulation of viral and cellular gene expression by E1A proteins encoded by the oncogenic adenovirus Type 12. Curr. Top. Microbiol. Immunol. 199/III:1995;82-112.
6. Brockmann D., Bury C., Kröner G., Kirch H.-C., Esche H. Repression of the c-Jun trans-activation function by the adenovirus type 12 E1A 52R protein correlates with the inhibition of phosphorylation of the c-Jun activation domain. J. Biol. Chem. 270(18):1995;10754-10763.
7. Chang C.-H., Kostrub C.F., Burton Z.F. Rap30/74 (transcription factor IIF) is required for promoter escape by RNA polymerase II. J. Biol. Chem. 268(27):1993;20482-20489.
8. Dorsman J.C., Hagmeyer B.M., Veenstra J., Elferich P., Nabben N., Zantema A., Van der Eb A.J. The N-terminal region of the adenovirus type 5 E1A proteins can repress expression of cellular genes via two distinct but overlapping domains. J. Virol. 69(5):1995;2962-2967.
9. Gedrich R.W., Bayley S.T., Engel D.A. Induction of AP-1 DNA-binding activity and c-fos mRNA by the adenovirus 243R E1A protein and cyclic AMP requires domains necessary for transformation. J. Virol. 66(10):1992;5849-5859.
10. Kraus V.B., Inostroza J.A., Yeung K., Reinberg D., Nevins J.R. Interaction of the Dr1 inhibitory factor with the TATA binding protein is disrupted by adenovirus E1A. Proc. Natl. Acad. Sci. USA. 91:1994;6279-6282.
11. Lee W.S., Kao C.C., Bryant G.O., Liu X., Berk A.J. Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell. 67:1991;365-376.
12. Lillie J.W., Green M.R. Transcription activation by the adenovirus E1A protein. Nature. 338(6210):1989;39-44.
13. Lipinski K.S., Kröner-Lux G., Esche H., Brockmann D. The E1A N-terminus (aa 1-29) of the highly oncogenic adenovirus type 12 harbours a trans-activation function not detectable in the non-oncogenic serotype 2. J. Gen. Virol. 78:1997;413-421.
14. Martin M.L., Lieberman P.M., Curran T. Fos-Jun dimerization promotes interaction of the basic region with TFIIE-34 and TFIIF. Mol. Cell. Biol. 16(5):1996;2110-2118.
15. Moran E. DNA tumor virus transforming proteins and the cell cycle. Cur. Opin. Gen. Dev. 3:1993;63-70.
16. Offringa R., Gebel S., van Dam H., Timmers M., Smits A., Zwart R., Stein B., Bos J.L., Van der Eb A.J., Herrlich P. A novel function of the transforming domain of E1A: repression of AP-1 activity. Cell. 62(8):1990;527-538.
17. Rochette-Egly C., Fromental C., Chambon P. General repression of enhanson activity by adenovirus-2 E1A proteins. Genes Dev. 4(1):1990;137-150.
18. Shenk T., Flint J. Transcriptional and transforming activities of the adenovirus E1A proteins. Adv. Cancer Res. 57:1991;47-83.
19. Smits P.H.M., De Wit L., Van der Eb A.J., Zantema A. The adenovirus E1A-associated 300 kDa adaptor protein counteracts the inhibition of the collagenase promoter by E1A and repress transformation. Oncogene. 12(7):1996;1529-1535.
20. Song C.-Z., Loewenstein P.M., Green M. TFIID is a direct functional target of the adenovirus E1A transcription-repression domain. Proc. Natl. Acad. Sci. USA. 92:1995;10330-10333.
21. Song C.-Z., Loewenstein P.M., Toth K., Tang Q., Nishikawa A., Green M. The adenovirus E1A repression domain disrupts the interaction between the TATA binding protein and the TATA box in a manner reversible by TFIIB. Mol. Cell. Biol. 17(4):1997;2186-2193.
22. Wang H.-G.H., Rikitake Y., Carter M.C., Yaciuk P., Abraham S.E., Zerler B., Moran E. Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67(1):1993;476-488.
23. Wang H.-G.H., Yaciuk P., Ricciardi R.P., Green M., Yokoyama K., Moran E. The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retinoblastoma protein but not p300. J. Virol. 67(8):1993;4804-4813.
24. Williams J., Williams M., Liu C., Telling G. Assessing the role of E1A in the differential oncogenicity of group A and group C human adenoviruses. Curr. Top. Microbiol. Immunol. 199/III:1995;149-175.
25. Yeung K., Kim S., Reinberg D. Functional dissection of a human Dr1-DRAP1 repressor complex. Mol. Cell. Biol. 17(1):1997;36-45.
26. Zawel L., Reinberg D. Common themes in assembly and function of eukaryotic transcription complexes. Annu. Rev. Biochem. 64:1995;533-561.